The AZEK Company Statistics
Total Valuation
CLNE has a market cap or net worth of $502.17 million. The enterprise value is $635.24 million.
Important Dates
The last earnings date was Thursday, August 7, 2025, after market close.
Earnings Date | Aug 7, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
CLNE has 219.29 million shares outstanding. The number of shares has decreased by -0.18% in one year.
Current Share Class | 219.29M |
Shares Outstanding | 219.29M |
Shares Change (YoY) | -0.18% |
Shares Change (QoQ) | -1.47% |
Owned by Insiders (%) | 2.14% |
Owned by Institutions (%) | 50.39% |
Float | 172.03M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 1.21 |
Forward PS | 1.16 |
PB Ratio | 0.85 |
P/TBV Ratio | 0.86 |
P/FCF Ratio | 19.54 |
P/OCF Ratio | 4.90 |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
The stock's EV/EBITDA ratio is 76.81, with an EV/FCF ratio of 24.71.
EV / Earnings | n/a |
EV / Sales | 1.51 |
EV / EBITDA | 76.81 |
EV / EBIT | n/a |
EV / FCF | 24.71 |
Financial Position
The company has a current ratio of 2.83, with a Debt / Equity ratio of 0.63.
Current Ratio | 2.83 |
Quick Ratio | 2.33 |
Debt / Equity | 0.63 |
Debt / EBITDA | 9.56 |
Debt / FCF | 14.54 |
Interest Coverage | -1.07 |
Financial Efficiency
Return on equity (ROE) is -30.77% and return on invested capital (ROIC) is -2.04%.
Return on Equity (ROE) | -30.77% |
Return on Assets (ROA) | -1.79% |
Return on Invested Capital (ROIC) | -2.04% |
Return on Capital Employed (ROCE) | -3.48% |
Revenue Per Employee | $728,906 |
Profits Per Employee | -$352,757 |
Employee Count | 577 |
Asset Turnover | 0.36 |
Inventory Turnover | 6.30 |
Taxes
Income Tax | -748,000 |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -5.37% in the last 52 weeks. The beta is 2.66, so CLNE's price volatility has been higher than the market average.
Beta (5Y) | 2.66 |
52-Week Price Change | -5.37% |
50-Day Moving Average | 2.00 |
200-Day Moving Average | 2.29 |
Relative Strength Index (RSI) | 63.48 |
Average Volume (20 Days) | 1,790,612 |
Short Selling Information
The latest short interest is 9.03 million, so 4.12% of the outstanding shares have been sold short.
Short Interest | 9.03M |
Short Previous Month | 8.86M |
Short % of Shares Out | 4.12% |
Short % of Float | 5.25% |
Short Ratio (days to cover) | 3.26 |
Income Statement
In the last 12 months, CLNE had revenue of $420.58 million and -$203.54 million in losses. Loss per share was -$0.91.
Revenue | 420.58M |
Gross Profit | 122.14M |
Operating Income | -33.85M |
Pretax Income | -78.96M |
Net Income | -203.54M |
EBITDA | 8.27M |
EBIT | -33.85M |
Loss Per Share | -$0.91 |
Full Income Statement Balance Sheet
The company has $240.76 million in cash and $373.82 million in debt, giving a net cash position of -$133.07 million or -$0.61 per share.
Cash & Cash Equivalents | 240.76M |
Total Debt | 373.82M |
Net Cash | -133.07M |
Net Cash Per Share | -$0.61 |
Equity (Book Value) | 596.85M |
Book Value Per Share | 2.70 |
Working Capital | 263.61M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was $102.55 million and capital expenditures -$76.85 million, giving a free cash flow of $25.71 million.
Operating Cash Flow | 102.55M |
Capital Expenditures | -76.85M |
Free Cash Flow | 25.71M |
FCF Per Share | $0.12 |
Full Cash Flow Statement Margins
Gross margin is 29.04%, with operating and profit margins of -8.05% and -48.40%.
Gross Margin | 29.04% |
Operating Margin | -8.05% |
Pretax Margin | -48.69% |
Profit Margin | -48.40% |
EBITDA Margin | 1.97% |
EBIT Margin | -8.05% |
FCF Margin | 6.11% |
Dividends & Yields
CLNE does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | 0.18% |
Shareholder Yield | n/a |
Earnings Yield | -40.53% |
FCF Yield | 5.12% |
Analyst Forecast
The average price target for CLNE is $3.80, which is 65.94% higher than the current price. The consensus rating is "Strong Buy".
Price Target | $3.80 |
Price Target Difference | 65.94% |
Analyst Consensus | Strong Buy |
Analyst Count | 4 |
Revenue Growth Forecast (5Y) | 22.39% |
EPS Growth Forecast (5Y) | n/a |
Stock Forecasts Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | n/a |
Lynch Upside | n/a |
Graham Number | n/a |
Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
CLNE has an Altman Z-Score of -0.26 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | -0.26 |
Piotroski F-Score | 4 |